2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.
about
Impacts of tissue-type plasminogen activator (tPA) on neuronal survivalConformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR.Proteolysis of proBDNF is a key regulator in the formation of memoryTissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke.Exogenous t-PA administration increases hippocampal mature BDNF levels. plasmin- or NMDA-dependent mechanism?Tissue plasminogen activator prevents white matter damage following stroke.Exercise influences hippocampal plasticity by modulating brain-derived neurotrophic factor processing.The neurovascular unit and combination treatment strategies for strokeDeleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemiaDistant Space Processing is Controlled by tPA-dependent NMDA Receptor Signaling in the Entorhinal Cortex.Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.
P2860
Q26777261-CB9F6FA3-D387-40E7-A3F4-62A43EDA9C2DQ27329809-884DFD29-74E6-4671-A935-3ACE0B7A38D4Q27438179-3CEF74B2-7D3D-4948-B416-6C77B4DE348CQ33369942-61E5E876-3FCE-462F-87D6-90FB56205D3BQ34432486-F555DBBD-AE9C-4736-9FF7-15808B4AC0DFQ35132128-B3612881-6001-44C7-A215-7B5CC01FB855Q35213585-27132A4A-FEBB-4154-9E07-807B9C77E7D2Q35576197-7BC2AF2B-96E1-4EC7-A9DF-A8A2E55341F6Q36124038-3766D4F6-2587-4246-912E-C35C5CEC0320Q36691135-86669922-8CDB-4882-931A-6C4C85DA2DA4Q39405161-CE66C621-C50D-413D-8B4D-45CF254E9CB6Q40795719-05561E42-214F-44FE-AD4A-5FE1A3810A0EQ48487420-333E6D2C-8787-4F31-B12F-002F7CCBC2CE
P2860
2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
2,7-Bis-(4-amidinobenzylidene) ...... ity both in vitro and in vivo.
@en
2,7-Bis-(4-amidinobenzylidene) ...... ity both in vitro and in vivo.
@nl
type
label
2,7-Bis-(4-amidinobenzylidene) ...... ity both in vitro and in vivo.
@en
2,7-Bis-(4-amidinobenzylidene) ...... ity both in vitro and in vivo.
@nl
prefLabel
2,7-Bis-(4-amidinobenzylidene) ...... ity both in vitro and in vivo.
@en
2,7-Bis-(4-amidinobenzylidene) ...... ity both in vitro and in vivo.
@nl
P2093
P2860
P50
P1476
2,7-Bis-(4-amidinobenzylidene) ...... ity both in vitro and in vivo.
@en
P2093
Antonio Ruocco
Frédéric Léveillé
Mónica Fernández-Monreal
P2860
P304
P356
10.1097/01.WCB.0000134476.93809.75
P50
P577
2004-10-01T00:00:00Z
P6179
1041316725